{"id":"CHEMBL1090090","canonicalSmiles":"NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F","inchiKey":"FYSRKRZDBHOFAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VX-702","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VX-702","Vx-702"],"crossReferences":{"PubChem":["103905258","137275870"],"drugbank":["DB05470"]},"count":1,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1091","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"ALEXXDVDDISNDU-JZYPGELDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE ACETATE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Barquinol hc","Chloromycetin hydrocort","Colifoam","Cortef acetate","Cortifoam","Cortril","Cortucid","Dricort","Epifoam","Framycort","Fucidin h","Genticin hc","Gentisone hc","Gppe ear susp","Gppe eye crm","Gppe foam aero","Hc45 hydrocort","Hemsol-hc","Hepacort plus","Hydrocal","Hydrocortisone acetate","Hydrocortone","Lanacort","Micort-hc","Neo-cortef","Orabase hca"],"synonyms":["Hydrocortisone 21-acetate","Hydrocortisone Acetate","Hydrocortisone acetate","NSC-741"],"crossReferences":{"DailyMed":["hydrocortisone%20acetate"],"PubChem":["56422202","855532"],"drugbank":["DB14539"],"chEBI":["17609"]},"count":5,"approvedIndications":["EFO_0009552","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0009552","EFO_0000274","EFO_0004208","HP_0004798","EFO_0005752","EFO_0005628"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and is indicated for eye inflammation and hemorrhoid and has 3 investigational indications."}
{"id":"CHEMBL1094982","canonicalSmiles":"O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H]1OC(=O)c1cccnc1)c1cccnc1","inchiKey":"MFZCIDXOLLEMOO-GYSGTQPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSITOL NIACINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hexopal","Linodil","Palohex"],"synonyms":["Inositol hexanicotinate","Inositol niacinate","Inositol nicotinate","WIN 9154"],"crossReferences":{"drugbank":["DB08949"],"chEBI":["31699"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL110739","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO","inchiKey":"OMFXVFTZEKFJBZ-HJTSIMOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTICOSTERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["11-b,21-Dihydroxypregn-3,20-dione","17-Deoxycortisol","Corticosteron","Corticosterone","NSC-9705","Preg-4-ene-3,20-dione,11-b,21-dihydroxy-"],"crossReferences":{"PubChem":["144204430","144208564","144213947","170466845","17389502","26751495","56423132","855741","90341091"],"Wikipedia":["Corticosterone"],"drugbank":["DB04652"],"chEBI":["16827"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1182","canonicalSmiles":"C[N+](C)(C)CC(=O)[O-]","inchiKey":"KWIUHFFTVRNATP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCINEBETAINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(Trimethylammonio)Acetate"],"crossReferences":{"PubChem":["144207060","144211476"],"Wikipedia":["Trimethylglycine"],"drugbank":["DB06756"],"chEBI":["17750"]},"childChemblIds":["CHEMBL3181853"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1195","canonicalSmiles":"CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC","inchiKey":"CAJIGINSTLKQMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPOXYCAINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Propoxycaine"],"crossReferences":{"PubChem":["11112410"],"Wikipedia":["Propoxycaine"],"drugbank":["DB09342"],"chEBI":["8496"]},"childChemblIds":["CHEMBL1769"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200368","canonicalSmiles":"O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1","inchiKey":"SPPTWHFVYKCNNK-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENTIROMIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chymex"],"synonyms":["BTPABA, PFT","Bentiromide","E-2663"],"crossReferences":{"Wikipedia":["Bentiromide"],"drugbank":["DB00522"],"chEBI":["31263"]},"childChemblIds":["CHEMBL3188891"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1200398","canonicalSmiles":"Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1.O=[N+]([O-])O","inchiKey":"ZHPWRQIPPNZNML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTOCONAZOLE NITRATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1295","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Butoconazole nitrate","Femstat","Femstat 3","Gynazole","Gynazole-1"],"synonyms":["Butoconazole nitrate","RS-35887","RS-35887-00-10-3"],"crossReferences":{"PubChem":["144204175","170464901","56463027"],"chEBI":["3241"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL1200469","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl","inchiKey":"JIVSXRLRGOICGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROMAZINE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL564","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prazine","Promazine Granules","Promazine hydrochloride","Protactyl","Sparine","Tranquazine","Verophene"],"synonyms":["Promazine chloride","Promazine hydrochloride"],"crossReferences":{"PubChem":["144203786","170464766","26747628","26747629","50106839","50106840","50106841","56422376","57288080","855749"],"chEBI":["8460"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1200632","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC.Cl","inchiKey":"GTNDZRUWKHDICY-DJHAJVGHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN PALMITATE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201289","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleocin","Clindamycin palmitate hydrochloride"],"synonyms":["Clindamycin palmitate hydrochloride","U-25,179 E","U-25179-E","U-25179E"],"crossReferences":{"DailyMed":["clindamycin%20palmitate%20hydrochloride"],"PubChem":["144206726"]},"count":2,"approvedIndications":["EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for acne and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200656","canonicalSmiles":"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O","inchiKey":"NCXMLFZGDNKEPB-FFPOYIOWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NATAMYCIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myprozine","Natacyn","Pimafucin","Pimaricin"],"synonyms":["ANTIBIOTIC A-5283","CL 12,625","CL-12625","E-235","E235","INS NO.235","INS-235","Natamycin","Pimaricin"],"crossReferences":{"DailyMed":["natamycin"],"PubChem":["144204112"],"Wikipedia":["Natamycin"],"drugbank":["DB00826"]},"count":3,"approvedIndications":["EFO_0000544","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for infection and eye infection and has 1 investigational indication."}
{"id":"CHEMBL1200691","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].[Mg+2]","inchiKey":"UEGPKNKPLBYCNK-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Magnesium acetate"],"crossReferences":{"DailyMed":["magnesium%20acetate"],"DrugCentral":["4489"],"PubChem":["144209755"],"Wikipedia":["Magnesium_acetate"],"drugbank":["DB13996"],"chEBI":["62964"]},"childChemblIds":["CHEMBL3989858"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200879","canonicalSmiles":"CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O.[Na+]","inchiKey":"KYITYFHKDODNCQ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"WARFARIN SODIUM","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1464","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Athrombin","Coumadin","Jantoven","Marevan","Panwarfin","Warfarin sodium"],"synonyms":["Warfarin sodium","Warfarin sodium salt"],"crossReferences":{"DailyMed":["warfarin%20sodium"],"PubChem":["144211862","50085469"]},"count":3,"approvedIndications":["EFO_0000275"],"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0009557","EFO_0003907","HP_0004936"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for atrial fibrillation and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200887","canonicalSmiles":"COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC.Cl","inchiKey":"WIIZEEPFHXAUND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOBENZAMIDE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201256","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tigan","Trimethobenzamide hydrochloride","Trimethobenzamide hydrochloride preservative free"],"synonyms":["NSC-37882","Trimethobenzamide HCl","Trimethobenzamide hydrochloride"],"crossReferences":{"DailyMed":["trimethobenzamide%20hydrochloride"],"PubChem":["144204016","170465132","26748292","56463340"]},"count":2,"approvedIndications":["EFO_0004888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for post operative nausea and vomiting and has 1 investigational indication."}
{"id":"CHEMBL1200950","canonicalSmiles":"C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2.[Br-]","inchiKey":"GKEGFOKQMZHVOW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLIDINIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL620","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quarzan"],"synonyms":["Clidinium bromide","RO 2-3773","Ro-23773"],"crossReferences":{"DailyMed":["clidinium%20bromide"],"PubChem":["144204086","170464768","56423127","855678"],"Wikipedia":["Clidinium_bromide"]},"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201042","canonicalSmiles":"CC(O)(P(=O)([O-])O)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"GWBBVOVXJZATQQ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDRONATE DISODIUM","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL871","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Didronel","Didronel iv","Didronel pmo","Etidronate disodium"],"synonyms":["Etidronate disodium"],"crossReferences":{"PubChem":["11112988","144205149","170464730"],"chEBI":["4906"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL1201365","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21","inchiKey":"KEDYTOTWMPBSLG-HILJTLORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMIPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ramiprilat"],"crossReferences":{"drugbank":["DB14208"],"chEBI":["77363"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201746","canonicalSmiles":"C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"OGSBUKJUDHAQEA-WMCAAGNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALATREXATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Folotyn"],"synonyms":["PDX","Pralatrexate"],"crossReferences":{"DailyMed":["pralatrexate"],"PubChem":["144206459"],"Wikipedia":["Pralatrexate"],"drugbank":["DB06813"],"chEBI":["71223"]},"count":18,"approvedIndications":["EFO_0000211","EFO_0000616","EFO_0000311","MONDO_0000430"],"linkedTargets":{"rows":["ENSG00000228716"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","MONDO_0019471","MONDO_0008170","EFO_0002913","MONDO_0002087","EFO_0000305","EFO_0003060","EFO_0000311","EFO_0000211","MONDO_0002158","EFO_0003032","MONDO_0008903","EFO_0000574","EFO_1001051","EFO_0001378","EFO_0006544","EFO_1000785","MONDO_0000430"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 4 approved and 14 investigational indications."}
{"id":"CHEMBL1201827","drugType":"Antibody","blackBoxWarning":true,"name":"PANITUMUMAB","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vectibix"],"synonyms":["ABX-EGF","E7.6.3","L01xc08","Panitumumab"],"crossReferences":{"DailyMed":["panitumumab"],"DrugCentral":["4955"],"Wikipedia":["Panitumumab"]},"count":30,"approvedIndications":["EFO_0000616","EFO_0000365","EFO_0005842","EFO_0004142","EFO_1001951","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","MONDO_0015686","EFO_0000681","MONDO_0007254","EFO_1000657","MONDO_0021063","EFO_0000305","EFO_1001951","MONDO_0001187","EFO_1001480","EFO_1000218","MONDO_0002158","MONDO_0002974","MONDO_0008903","EFO_0000707","EFO_0002618","EFO_0000616","EFO_0006859","EFO_0005922","EFO_0002916","EFO_0000503","MONDO_0008170","EFO_0000478","EFO_0005842","MONDO_0007576","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_0005221","EFO_0000311","MONDO_0005499","MONDO_0002529","EFO_0004142","MONDO_0002367","EFO_1000852","EFO_0000181","MONDO_0040678"],"count":37},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 6 approved and 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL121790","canonicalSmiles":"Cc1cccc(-c2nn3c(c2-c2ccc(F)cc2)CCC3)n1","inchiKey":"NBDZLUOYAAVYHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL121790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04480"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229971","canonicalSmiles":"O=c1[nH]cnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1","inchiKey":"VGONTNSXDCQUGY-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYINOSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26755575"],"drugbank":["DB02380"],"chEBI":["28997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230020","canonicalSmiles":"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F","inchiKey":"YZDJQTHVDDOVHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-4720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX-4720"],"crossReferences":{"drugbank":["DB06999"],"chEBI":["90295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231","canonicalSmiles":"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1","inchiKey":"XIQVNETUBQGFHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYBUTYNIN","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anturol","Contimin 2.5","Contimin 5","Cystrin","Ditropan","Ditropan xl","Kentera","Lyrinel xl","Oxybutynin","Oxytrol","Oxytrol for women","Promictuline","Urimin"],"synonyms":["Ditropan","Oxybutynin"],"crossReferences":{"DailyMed":["oxybutynin","oxybutynin%20chloride"],"PubChem":["174006905","50105262","90341037"],"Wikipedia":["Oxybutynin"],"drugbank":["DB01062"],"chEBI":["7856"]},"childChemblIds":["CHEMBL1133"],"count":9,"approvedIndications":["HP_0000020","EFO_1000781","HP_0000103"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["MONDO_0024290","EFO_0006865","HP_0001268","EFO_0001663","EFO_0009562","HP_0001347","EFO_0003103","EFO_0000512","HP_0000020","HP_0000975","EFO_1000781","EFO_0003918","EFO_0003877","HP_0000011","EFO_0003956","HP_0000103"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL1231378","canonicalSmiles":"O=C1c2ccccc2N=C2N(c3ccccc3)CC[C@@]12O","inchiKey":"DOMYOVZXZIZTRD-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231378","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07470"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123154","canonicalSmiles":"O=C(O)c1cc(-c2ccc(Cl)cc2Cl)ccc1O","inchiKey":"SKAFZYDMDHPPJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123154","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07047"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231592","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"BHYOQNUELFTYRT-DPAQBDIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231592","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01990"],"chEBI":["41321"]},"childChemblIds":["CHEMBL4475544"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232181","canonicalSmiles":"O=C(O)C(c1ccccc1)c1ccccc1","inchiKey":"PYHXGXCGESYPCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENYLACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["47193691"],"drugbank":["DB03588"],"chEBI":["41967"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232182","canonicalSmiles":"OCc1cccc(F)c1F","inchiKey":"JSFGDUIJQWWBGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-Difluorobenzyl Alcohol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Difluorobenzyl Alcohol"],"crossReferences":{"drugbank":["DB04312"],"chEBI":["41883"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233249","canonicalSmiles":"CC(C)CCC[C@@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"MCKLJFJEQRYRQT-MGNSQDQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233249","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233511","canonicalSmiles":"O=P(O)(O)O[C@H]1[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H]1OP(=O)(O)O","inchiKey":"IMQLKJBTEOYOSI-GPIVLXJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHYTIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E391","Fytic acid","NSC-269896","Phytic acid","Phytic acid solution"],"crossReferences":{"drugbank":["DB14981"],"chEBI":["17401"]},"childChemblIds":["CHEMBL3989600","CHEMBL2106435"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1234904","canonicalSmiles":"Nc1ncc(C(=O)c2cccc(Br)c2)o1","inchiKey":"YDCMMVTWXORJGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234904","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235764","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)n1","inchiKey":"SDWIOXKHTFOULX-AFCXAGJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBAVIRIN MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-274937"],"crossReferences":{"drugbank":["DB14663"]},"childChemblIds":["CHEMBL3249842","CHEMBL3249841"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1240705","canonicalSmiles":"O=C(O)C1=CC[C@@H]2CC(=O)N12","inchiKey":"BSIMZHVOQZIAOY-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBAPENEM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbapenem","SQ-27860"],"crossReferences":{"chEBI":["615"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1269257","canonicalSmiles":"CC(C)N(C(=O)CN1C(=O)[C@H](NC(=O)Nc2cccc(C(=O)O)c2)C(=O)N(c2ccccc2)c2ccccc21)c1ccccc1","inchiKey":"CABBMMXFOOZVMS-PMERELPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1269257","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1336","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1","inchiKey":"MLDQJTXFUGDVEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORAFENIB","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"crossReferences":{"DailyMed":["sorafenib%20tosylate"],"PubChem":["103904444","124893321","124893323","50100118","50112741"],"Wikipedia":["Sorafenib"],"drugbank":["DB00398"],"chEBI":["50924"]},"childChemblIds":["CHEMBL1200485","CHEMBL4297490","CHEMBL1760433"],"count":68,"approvedIndications":["EFO_0000616","EFO_0000681","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000157764","ENSG00000113721","ENSG00000157404","ENSG00000132155","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000637","EFO_0000365","EFO_0000558","EFO_0000756","EFO_0000681","EFO_1000657","EFO_1001052","EFO_0000228","EFO_1001951","EFO_0000565","EFO_0000588","EFO_0000339","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000501","MONDO_0018531","EFO_0000641","EFO_0002918","MONDO_0015277","EFO_0000198","EFO_0002618","EFO_0003893","EFO_1000292","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0009907","EFO_1001968","EFO_0002500","EFO_0000666","EFO_0000224","MONDO_0008315","EFO_1001967","MONDO_0002691","EFO_1000489","EFO_0001061","MONDO_0044787","EFO_0003841","MONDO_0000544","EFO_0003032","EFO_0000335","MONDO_0000831","EFO_0004284","EFO_0008524","EFO_0000574","EFO_1000613","EFO_0001378","EFO_1000796","MONDO_0021640","EFO_0003086","EFO_0000292","EFO_0002938","EFO_1001346","EFO_1001901","MONDO_0004192","EFO_1001465","MONDO_0007254","EFO_0003871","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0004252","MONDO_0044937","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0003860","EFO_0006352","EFO_0000673","EFO_0000196","EFO_0004212","EFO_0002499","MONDO_0020743","EFO_0000707","EFO_1000158","EFO_0002914","EFO_0000616","EFO_0005088","EFO_1000616","MONDO_0019457","Orphanet_44890","EFO_0000403","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0002501","EFO_0007535","MONDO_0021038","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000640","EFO_0003865","EFO_0006861","EFO_0000095","EFO_0002892","EFO_0001421","EFO_0000702","MONDO_0017386","MONDO_0002367","EFO_0004142","MONDO_0003219","MONDO_0024880","EFO_0000691","EFO_0000519","MONDO_0044926"],"count":112},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 65 investigational indications."}
{"id":"CHEMBL1357648","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.Cl.O.O","inchiKey":"YVNAYSHNIILOJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMODIAQUINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL682","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Camoquin","Camoquin hydrochloride"],"synonyms":["Amodiaquine hydrochloride"],"crossReferences":{"PubChem":["11112979","144204316","174006660"],"chEBI":["50652"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL136560","canonicalSmiles":"C[C@H](N)[C@H](O)c1ccccc1","inchiKey":"DLNKOYKMWOXYQA-CBAPKCEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(1R,2S)-PHENYLPROPANOLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Phenylpropanolamine"],"drugbank":["DB00397"],"chEBI":["80680"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1371200","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]2(O)CCC(=O)[O-].[K+]","inchiKey":"JTZQCHFUGHIPDF-RYVBEKKQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CANRENOATE POTASSIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1616951","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Soldactone","Spiroctan-m"],"synonyms":["Canrenoate potassium","Canrenone free acid potassium salt","Potassium canrenoate","SC-14266"],"crossReferences":{"PubChem":["144204351","56463334"]},"count":2,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0008585","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL1373467","canonicalSmiles":"O=c1c(-c2ccccc2)c1-c1ccccc1","inchiKey":"HCIBTBXNLVOFER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1373467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205875","170465593","26719757","29217871"],"drugbank":["DB12173"],"chEBI":["53074"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL139367","canonicalSmiles":"CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N","inchiKey":"XRQDFNLINLXZLB-CKIKVBCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERAMIVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Peramivir","Peramivir hydrate","Peramivir trihydrate","RWJ-270201"],"crossReferences":{"DailyMed":["peramivir"],"drugbank":["DB06614"],"chEBI":["85202"]},"childChemblIds":["CHEMBL3989402"],"count":2,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for viral disease and has 1 investigational indication."}
{"id":"CHEMBL142652","canonicalSmiles":"OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"HSTZMXCBWJGKHG-CUYWLFDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICEID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E)-Piceid","(E)-Polydatin","Piceid","Resveratrol 3-.beta.-mono-d-glucoside","Trans-Piceid"],"crossReferences":{"PubChem":["26719879","49681745","525087"],"Wikipedia":["Piceid"],"drugbank":["DB11263"],"chEBI":["8198"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL148169","canonicalSmiles":"Cc1cc(COc2ccc([C@]3(C)CCN([C@H](C)C(=O)NO)C3=O)cc2)c2ccccc2n1","inchiKey":"YDMIPBHQKFOFQW-NSYGIPOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IK-682","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IK-682"],"crossReferences":{"drugbank":["DB07145"],"chEBI":["40083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1515624","canonicalSmiles":"C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1.Cl","inchiKey":"LUJOSUPKSLRJME-ZUOBHZEMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1515624","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201774","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56323643","56463007"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1534878","canonicalSmiles":"CC(C)NNC(=O)c1ccncc1.O=S(=O)(O)O","inchiKey":"FYEMNIIBXSJOLP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRONIAZID SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL92401","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204894","170466357","26748329","26748330"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1544","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O","inchiKey":"AUYYCJSJGJYCDS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LIOTHYRONINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cytomel","Tertroxin"],"synonyms":["Euthroid-0.5","Euthroid-1","Euthroid-2","Euthroid-3","Levothyroxine sodium related compound liothyronine","Liothyronine","NSC-80203","Rathyronine","Thyrolar-0.25","Thyrolar-0.5","Thyrolar-1","Thyrolar-2","Thyrolar-3","Thyrolar-5","Triiodothyronine (T3 Or Liothyronine, Active) (6-11%)","Triostat"],"crossReferences":{"DailyMed":["liothyronine%20sodium"],"PubChem":["11532858","124877498","144203580","144212260","26753840","4253003"],"Wikipedia":["Triiodothyronine"],"drugbank":["DB00279"],"chEBI":["18258"]},"childChemblIds":["CHEMBL2106622","CHEMBL2107398","CHEMBL1356342","CHEMBL1201119"],"count":7,"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000275","EFO_0005207","MONDO_0007254","EFO_0003929","MONDO_0008315","EFO_0003885","EFO_0003840","EFO_0000289","MONDO_0002050","EFO_0003841","EFO_0003761","HP_0030680","EFO_0004705"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1585","canonicalSmiles":"O=C(CCBr)N1CCN(C(=O)CCBr)CC1","inchiKey":"NJBFOOCLYDNZJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPOBROMAN","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vercyte"],"synonyms":["A-8103","NSC-25154","Pipobroman"],"crossReferences":{"PubChem":["144204955","170465158","26748793","86412"],"Wikipedia":["Pipobroman"],"drugbank":["DB00236"],"chEBI":["8242"]},"count":2,"approvedIndications":["EFO_0000616"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and is indicated for neoplasm and has 1 investigational indication."}
{"id":"CHEMBL1593568","canonicalSmiles":"Cl.NCc1ccc(S(N)(=O)=O)cc1","inchiKey":"SIACJRVYIPXFKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAFENIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL419","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mafenide hydrochloride"],"crossReferences":{"PubChem":["144203974","170465055","26748108","85273765"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15976","canonicalSmiles":"NC(=O)C(=O)O","inchiKey":"SOWBFZRMHSNYGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxalamic acid","Oxamate","Oxamic Acid"],"crossReferences":{"PubChem":["50111189","90341224"],"drugbank":["DB03940"],"chEBI":["18058"]},"childChemblIds":["CHEMBL1256289"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628569","canonicalSmiles":"NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2","inchiKey":"MQTUXRKNJYPMCG-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROBALZOTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd-7371","NAD-299","Robalzotan"],"crossReferences":{"drugbank":["DB06538"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1637","canonicalSmiles":"Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1","inchiKey":"OKKDEIYWILRZIA-OSZBKLCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMCITABINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL888","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"crossReferences":{"DailyMed":["gemcitabine%20hydrochloride"],"PubChem":["144206197","170465129"],"chEBI":["31647"]},"count":55,"approvedIndications":["EFO_0002618","EFO_0001075","MONDO_0008170","MONDO_0007254","EFO_0000305","EFO_0003060"],"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000062822","ENSG00000146143","ENSG00000167325","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_0004708","EFO_0001075","EFO_0003859","EFO_1001958","MONDO_0003890","EFO_0000681","EFO_1000231","EFO_1001951","EFO_0000565","EFO_1001952","MONDO_0015760","EFO_0000588","EFO_0000096","MONDO_0002974","MONDO_0008903","EFO_1000251","MONDO_0005411","EFO_0008528","EFO_0001416","EFO_0002618","Orphanet_145","MONDO_0019465","EFO_0000466","MONDO_0021321","MONDO_0008170","EFO_1001973","MONDO_0008627","MONDO_0008315","EFO_1001959","MONDO_0002691","MONDO_0044889","EFO_0005537","EFO_0000574","EFO_0006544","EFO_1001051","EFO_0001378","EFO_1000613","EFO_1000624","EFO_1000172","EFO_1000412","EFO_0000292","MONDO_0015686","MONDO_0004192","MONDO_0007254","EFO_0000708","EFO_1001469","MONDO_0002087","EFO_0004252","EFO_0000305","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1000044","MONDO_0002158","EFO_1000043","EFO_1001974","EFO_0000183","EFO_1001963","EFO_0002914","EFO_0000616","EFO_0006859","EFO_1000314","EFO_0000313","EFO_0003060","EFO_0006738","EFO_1001961","HP_0001907","EFO_0000304","EFO_0006861","EFO_0006475","Orphanet_238510","EFO_0002517","MONDO_0011962","MONDO_0002367","EFO_0000691"],"count":75},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 approved and 49 investigational indications."}
{"id":"CHEMBL165315","canonicalSmiles":"O=C(O)CCCCCn1c(C(=O)O)cc2cc(OCc3c(Cl)cccc3Cl)ccc21","inchiKey":"JTGPYFFQVOIJKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL165315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1673303","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)O[C@@H](C1CC1)C=C2","inchiKey":"HWJPWWYTGBZDEG-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-ICLAPRIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Iclaprim"],"crossReferences":{"drugbank":["DB07938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL167874","canonicalSmiles":"Cc1cc(CCCCCCCOc2ccc(C3=N[C@@H](C)CO3)cc2Cl)on1","inchiKey":"WOJFAPUTPSWFLJ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL167874","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08722"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1681","canonicalSmiles":"O=C(O)CNC(=O)c1ccccc1I","inchiKey":"CORFWQGVBFFZHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOHIPPURATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iodohippurate"],"crossReferences":{"PubChem":["144205379","170465302","29216137"],"drugbank":["DB15445"]},"childChemblIds":["CHEMBL1200763","CHEMBL1200439","CHEMBL2104818"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL169526","canonicalSmiles":"CC(C)(C)COc1ccc(-n2cc(C(=O)O)cn2)cc1C#N","inchiKey":"AETHRPHBGJAIBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL169526","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275979"],"drugbank":["DB03841"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1704","canonicalSmiles":"CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O.Cl","inchiKey":"KPKFFYOMPGOQRP-BOXHHOBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIROFIBAN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL916","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aggrastat"],"synonyms":["L-700462"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1721885","canonicalSmiles":"Cc1[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1","inchiKey":"CTNPALGJUAXMMC-PMFHANACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-014813","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-14813","Su-014813","Su-14813"],"crossReferences":{"PubChem":["50100117"]},"count":2,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000113721","ENSG00000157404","ENSG00000122025"],"count":7},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1742483","canonicalSmiles":"CC[C@@H](O)/C=C/C=C\\C[C@@H](O)/C=C/C=C/C=C\\[C@@H](O)CCCC(=O)O","inchiKey":"AOPOCGPBAIARAV-OTBJXLELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESOLVIN E1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.218.407E","RX-10001","Resolvin e1","Rx-10001"],"crossReferences":{"drugbank":["DB13105"],"chEBI":["81559"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743017","drugType":"Antibody","blackBoxWarning":false,"name":"FEZAKINUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fezakinumab","ILV-094"],"count":3,"linkedTargets":{"rows":["ENSG00000127318"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000676","EFO_0000274"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1761322","canonicalSmiles":"CCS(=O)(=O)CCCC12CCC(c3nnc(-c4ccccc4C(F)(F)F)n3C)(CC1)CC2","inchiKey":"ORQZQBUNAMJFCY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0736","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK0736","Mk-0736","Mk0736"],"crossReferences":{"drugbank":["DB15209"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL182323","canonicalSmiles":"COc1cccc(Cn2c(C(=O)NC3CCN(C(C)C)CC3)cc3ccccc32)c1","inchiKey":"GIPCBGDQVGKMPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL182323","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07973"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL185885","canonicalSmiles":"O=Cc1ccc(CO)o1","inchiKey":"NOEGNKMFWQHSLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AES-103","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-(hydroxymethyl)-2-furaldehyde","Aes-103","NSC-40738"],"crossReferences":{"PubChem":["144209090","144213856","17389229"],"Wikipedia":["Hydroxymethylfurfural"],"drugbank":["DB12298"],"chEBI":["412516"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1875086","canonicalSmiles":"COC(C)(C)CCC[C@H](C)C/C=C/C(C)=C/C(=O)OC(C)C","inchiKey":"NFGXHKASABOEEW-GYMWBFJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOPRENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methoprene"],"crossReferences":{"PubChem":["144211726","26757220"],"drugbank":["DB11495"],"chEBI":["39255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL188921","canonicalSmiles":"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1","inchiKey":"OWYLAEYXIQKAOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFLOMEDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buflomedil"],"crossReferences":{"PubChem":["11112743","174006865","26757801"],"Wikipedia":["Buflomedil"],"drugbank":["DB13510"]},"childChemblIds":["CHEMBL1715107"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1923234","canonicalSmiles":"C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1","inchiKey":"VFUAJMPDXIRPKO-LQELWAHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WP 1066","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Wp 1066"],"crossReferences":{"drugbank":["DB12679"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1949708","canonicalSmiles":"Nc1nc(C(=O)N[C@H](CO)C(=O)O)c(N)nc1C(=O)N[C@H](CO)C(=O)O","inchiKey":"XHNJXRDGTITISI-QWWZWVQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELMAPIRAZIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lumitrace"],"synonyms":["MB-102","Mb-102","Relmapirazin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL195368","canonicalSmiles":"CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"HOVAGTYPODGVJG-VEIUFWFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Methyl Alpha-D-Mannopyranoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyl Alpha-D-Mannopyranoside","Methyl Alpha-D-Mannoside"],"crossReferences":{"drugbank":["DB01979"],"chEBI":["43943"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL195660","canonicalSmiles":"CCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"HMXHURAGFHWODC-WOUKDFQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL195660","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07052"],"chEBI":["74046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1963249","canonicalSmiles":"C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1","inchiKey":"WGYPAJVJMXQXTR-ABNZCKJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULIMORELIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TZP-101 FREE BASE","Ulimorelin"],"crossReferences":{"drugbank":["DB12128"]},"childChemblIds":["CHEMBL1923502","CHEMBL3926779"],"count":1,"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","MONDO_0004567","HP_0002579","EFO_1000948"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL197672","canonicalSmiles":"C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F","inchiKey":"SCVHJVCATBPIHN-SJCJKPOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMRICASAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emricasan","IDN 6556","IDN-6556","PF 03491390","PF-03491390","VAY-785","VAY785"],"crossReferences":{"drugbank":["DB05408"]},"count":7,"linkedTargets":{"rows":["ENSG00000164305","ENSG00000137757","ENSG00000064012","ENSG00000105141","ENSG00000196954","ENSG00000003400","ENSG00000132906","ENSG00000137752","ENSG00000106144","ENSG00000204403","ENSG00000138794","ENSG00000165806"],"count":12},"linkedDiseases":{"rows":["EFO_0001422","EFO_0004220","EFO_0010282","EFO_0001421","EFO_1001249","EFO_1001345","EFO_0000400"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL200849","canonicalSmiles":"NNC(=O)c1ccc(-c2ccccc2Cl)o1","inchiKey":"XQMRHWSGTVEDFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200849","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08757"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2023898","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C","inchiKey":"FKRSSPOQAMALKA-CUPIEXAXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DACLATASVIR","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daklinza"],"synonyms":["BMS 790052","BMS-790052","Daclatasvir","EBP 883","EBP-883"],"crossReferences":{"Wikipedia":["Daclatasvir"],"drugbank":["DB09102"],"chEBI":["82977"]},"childChemblIds":["CHEMBL2303621"],"count":6,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for viral disease and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2031739","canonicalSmiles":"[11CH3]NC(=O)c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1","inchiKey":"WROHEWWOCPRMIA-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]GSK-189254","maximumClinicalTrialPhase":0,"parentId":"CHEMBL517140","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[11C]GSK-189254"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL207095","canonicalSmiles":"O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl","inchiKey":"JCXZHFCBNFFHRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207095","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07312"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103840","canonicalSmiles":"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12","inchiKey":"PIMQWRZWLQKKBJ-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINACICLIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dinaciclib","Mk-7965","SCH 727965","SCH-727965"],"crossReferences":{"drugbank":["DB12021"]},"count":9,"linkedTargets":{"rows":["ENSG00000123374","ENSG00000164885","ENSG00000136807","ENSG00000170312"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000044","MONDO_0000544","EFO_0006861","EFO_0000220","EFO_0000095","EFO_0000756","MONDO_0001023","MONDO_0007254","EFO_0000222","EFO_0001378","MONDO_0023619","MONDO_0003865"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2104146","canonicalSmiles":"O=C([O-])O.O=S(=O)(O)c1cc(I)c(O)c2ncccc12.[Na+]","inchiKey":"FNXKBSAUKFCXIK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHINIOFON","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1788402","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chiniofon"],"crossReferences":{"DrugCentral":["4362"],"drugbank":["DB13379"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104397","canonicalSmiles":"O=[Ca]","inchiKey":"ODINCKMPIJJUCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIME","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium oxide","Citrus aurantiifolia","E-529","INS NO.529","INS-529","Lime"],"crossReferences":{"drugbank":["DB15648"],"chEBI":["31344"]},"childChemblIds":["CHEMBL2107006"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2104797","canonicalSmiles":"C[N+]1(CCC(O)(c2ccccc2)c2cccs2)CCOCC1.[I-]","inchiKey":"IOFXEUZPIIUQAG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TIEMONIUM IODIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110651","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TE 114","Tiemonium iodide"],"crossReferences":{"drugbank":["DB13666"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104927","canonicalSmiles":"CN(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)[C@H](c1ccccc1)N1CCN(CC2CC2)CC1","inchiKey":"HUTHJVYJUPXHDF-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIGOPITANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIF 1149 BS","BIIF 1149 CL","BIIF-1149 BS","BIIF-1149-BS","Biif 1149","Figopitant"],"crossReferences":{"drugbank":["DB12122"]},"childChemblIds":["CHEMBL3542235"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105036","canonicalSmiles":"O=C(O)Cn1cc(I)c(=O)c(I)c1.OCCNCCO","inchiKey":"RERHJVNYJKZHLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOPYRACET","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110615","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Diodrast"],"synonyms":["Diodone","Iodopyracet"],"crossReferences":{"DrugCentral":["4449"],"drugbank":["DB13568"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105650","canonicalSmiles":"Cc1ncccc1OC[C@@H]1CCCN1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"WOYZAVAGHHPUIK-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POZANICLINE TARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL127071","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-87089.74","Pozanicline tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105675","canonicalSmiles":"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1","inchiKey":"DQJDBUPLRMRBAB-WZTVWXICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFAMIDIS MEGLUMINE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103837","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vyndaqel"],"synonyms":["FX-1006A","Tafamidis meglumine"],"crossReferences":{"DailyMed":["tafamidis%20meglumine"],"chEBI":["79345"]},"count":5,"approvedIndications":["EFO_0000318","EFO_1001875","Orphanet_85443"],"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_0009562","EFO_0000318","EFO_1001875","Orphanet_85443","Orphanet_85447"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2105807","canonicalSmiles":"CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N","inchiKey":"WQGJEAMPBSZCIF-HKSLRPGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MADURAMICIN","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1909065","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL 273,703","Maduramicin"],"crossReferences":{"drugbank":["DB11525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106071","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(=O)NCO)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"GJGDLRSSCNAKGL-KMVLDZISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMOCYCLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlormethylencycline","Clomocycline"],"crossReferences":{"drugbank":["DB00453"],"chEBI":["59589"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL210651","canonicalSmiles":"Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1","inchiKey":"RYMCFYKJDVMSIR-RNFRBKRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRICITABINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apricitabine"],"crossReferences":{"Wikipedia":["Apricitabine"],"drugbank":["DB12855"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106751","canonicalSmiles":"CC(C)CN(C[C@@H](OP(=O)([O-])[O-])[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1.[Na+].[Na+]","inchiKey":"FZMGUXZZROZJIT-KMIZVRHLSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSAMPRENAVIR SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1664","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosamprenavir sodium","GW 433908A"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106966","canonicalSmiles":"Cc1ccnc(NC(=O)C(C)c2cccc(C(=O)c3ccccc3)c2)c1","inchiKey":"ASFKKFRSMGBFRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIKETOPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piketoprofen"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107806","canonicalSmiles":"C=Cc1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)[O-])C(=O)[O-])c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)[O-])[C@@H](CCC(=O)[O-])[C@@H]3C.[Na+].[Na+].[Na+].[Na+]","inchiKey":"KPALSRNVSRWOPA-YJFNSWLASA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAPORFIN SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111186","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LS-11","ME 2906","ME-2906","Talaporfin sodium","Talaporfin tetrasodium salt"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2107826","canonicalSmiles":"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2nccc(=O)n21","inchiKey":"DJXRIQMCROIRCZ-XOEOCAAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIBEGRON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KRP-114V","Mk4618","Vibegron"],"crossReferences":{"drugbank":["DB14895"]},"count":3,"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_1000781","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107840","drugType":"Small molecule","blackBoxWarning":true,"name":"PATIROMER CALCIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Veltassa"],"synonyms":["Patiromer calcium","Patiromer sorbitex calcium","RLY5016"],"crossReferences":{"DailyMed":["patiromer%20sorbitex%20calcium"],"DrugCentral":["5056"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108057","drugType":"Antibody","blackBoxWarning":false,"name":"URTOXAZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TMA-15","Urtoxazumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108345","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TRABEDERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-12009 FREE ACID","Trabedersen"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108660","drugType":"Antibody","blackBoxWarning":false,"name":"TUCOTUZUMAB CELMOLEUKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 273066","EMD-273066","HUKS-IL2","KSA-INTERLEUKIN-2","Tucotuzumab celmoleukin"],"count":1,"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["MONDO_0008170"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108866","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"STARCH","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bio-sorb"],"synonyms":["Corn starch","Potato starch","Starch","Wheat starch"],"count":11,"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL2108887","drugType":"Antibody","blackBoxWarning":false,"name":"AFELIMOMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Segard"],"synonyms":["Afelimomab","LU-54107","MAK-195F"],"count":1,"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000540"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109177","drugType":"Antibody","blackBoxWarning":false,"name":"ODULIMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afolimomab","Odulimomab","anti-LFA1"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109341","drugType":"Antibody","blackBoxWarning":false,"name":"CCR5MAB004","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCR5MAB004","Ccr5mab004"],"count":1,"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109366","drugType":"Antibody","blackBoxWarning":false,"name":"ANTI-TAC 90 Y-HAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-TAC 90 Y-HAT","Anti-tac 90 y-hat"],"count":2,"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000183","EFO_0005952"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109595","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-157","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-157","MEDI-9929"],"count":1,"linkedTargets":{"rows":["ENSG00000145777"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109673","drugType":"Unknown","blackBoxWarning":false,"name":"PTI-6D2 188RE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PTI-188","PTI-6D2","Pti-6d2 188re"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL211312","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"JSRLJPSBLDHEIO-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYURIDINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxyuridinemonophosphate"],"crossReferences":{"Wikipedia":["Deoxyuridine_monophosphate"],"drugbank":["DB03800"],"chEBI":["17622"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL213618","canonicalSmiles":"CNc1nccc(-c2ccc(C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl)s2)n1","inchiKey":"HHOVRZGUSBMKKU-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213618","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07235"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2165402","canonicalSmiles":"CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1O)[C@H]1[C@@H](C[C@H]3C)C1(C)C","inchiKey":"VEBVPUXQAPLADL-POYOOMFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INGENOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ingenol"],"crossReferences":{"chEBI":["5922"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL217899","canonicalSmiles":"CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2","inchiKey":"DHCOPPHTVOXDKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOFIMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-325,366","CP-325366","Tofimilast"],"crossReferences":{"drugbank":["DB11681"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL218382","canonicalSmiles":"COc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OS(N)(=O)=O)CC[C@@H]12","inchiKey":"AQSNIXKAKUZPSI-SSTWWWIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL218382","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08416"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL219568","canonicalSmiles":"Nc1nc2[nH]cnc2c(=O)[nH]1","inchiKey":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanine","Valacyclovir hydrochloride, guanine-","Valganciclovir hydrochloride impurity b"],"crossReferences":{"Wikipedia":["Guanine"],"drugbank":["DB02377"],"chEBI":["16235"]},"childChemblIds":["CHEMBL1906087","CHEMBL2028459","CHEMBL141183"],"count":14,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL219841","canonicalSmiles":"CN(C)C(=O)c1cc(-c2n[nH]cc2-c2ccccc2)c[nH]1","inchiKey":"OPBUUQBZKJSWTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL219841","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06877"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220467","canonicalSmiles":"Cc1c(-c2ccc(-c3ccccc3)cc2)nc2ccc(F)cc2c1C(=O)O","inchiKey":"WYKKHJQZENLZID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03480"]},"childChemblIds":["CHEMBL288708"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL22148","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccccc1","inchiKey":"XREDUPOVEQDQQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GNF-Pf-26","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-26","TCMDC-124296"],"crossReferences":{"drugbank":["DB07577"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222021","canonicalSmiles":"O=Cc1ccc(O)c(O)c1","inchiKey":"IBGBGRVKPALMCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOCATECHUALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dihydroxybenzaldehyde","Protocatechualdehyde"],"crossReferences":{"PubChem":["56422369","8139931"],"Wikipedia":["Protocatechuic_aldehyde"],"drugbank":["DB11268"],"chEBI":["50205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2252949","canonicalSmiles":"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2","inchiKey":"DSSYKIVIOFKYAU-OIBJUYFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-CAMPHOR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["251919659"],"drugbank":["DB11345"],"chEBI":["15397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL229430","canonicalSmiles":"CC(=O)Nc1nc2c(Oc3cc(-c4ccc(C(F)(F)F)cc4)ncn3)cccc2s1","inchiKey":"YUTIXVXZQIQWGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-517","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-517","Amg-517"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230001","canonicalSmiles":"CO/C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1","inchiKey":"WFDXOXNFNRHQEC-GHRIWEEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZOXYSTROBIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNDI1511705","TCMDC-125883"],"crossReferences":{"PubChem":["144214048","26757224"],"Wikipedia":["Azoxystrobin"],"drugbank":["DB07401"],"chEBI":["40909"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2303621","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C.Cl.Cl","inchiKey":"BVZLLUDATICXCI-JMSCDMLISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DACLATASVIR DIHYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2023898","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daklinza"],"synonyms":["BMS 790052-05","BMS-790052-05","Daclatasvir dihydrochloride","Daclatasvir hydrochloride"],"crossReferences":{"chEBI":["83800"]},"count":1,"approvedIndications":["EFO_0004220"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for chronic hepatitis c virus infection. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2308885","canonicalSmiles":"CCCC(=O)O[C@]1(C(=O)CCl)[C@H](C)C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)C(=O)C[C@@]21C","inchiKey":"FBRAWBYQGRLCEK-RJFLZJKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOBETASONE BUTYRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clobavate","Clobet","Cloburate","Cloburate-n","Eumovate","Eumovate n","Trimovate"],"synonyms":["CCI 5537","CCI-5537","Clobetasone","Clobetasone 17-butyrate","Clobetasone butyrate","GR 2/1214"],"count":2,"approvedIndications":["EFO_0005752"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye inflammation and has 1 investigational indication."}
{"id":"CHEMBL2331680","canonicalSmiles":"CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1","inchiKey":"RGJOJUGRHPQXGF-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7603","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0349","Rg-7603"],"crossReferences":{"drugbank":["DB13072"]},"childChemblIds":["CHEMBL2331681"],"count":1,"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2346738","canonicalSmiles":"Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1","inchiKey":"LZXMUJCJAWVHPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPRAGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADX-48621","ADX48621","Adx48621","Dipraglurant"],"crossReferences":{"drugbank":["DB12733"]},"count":1,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0002508"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2346976","canonicalSmiles":"CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1","inchiKey":"JMEYDSHPKCSIJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD3514","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd3514","CS-1443"],"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL24147","canonicalSmiles":"Oc1cccc(O)c1","inchiKey":"GHMLBKRAJCXXBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESORCINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["D.d.d.","Tilloderm"],"synonyms":["Resorcin","Resorcinol"],"crossReferences":{"PubChem":["144204691","144209615","144210460","170465462","17389742"],"Wikipedia":["Resorcinol"],"drugbank":["DB11085"],"chEBI":["27810"]},"count":2,"approvedIndications":["EFO_1001888","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for acne and eye infection."}
{"id":"CHEMBL257468","canonicalSmiles":"O=C(Cc1cccs1)N[C@H](B(O)O)c1cccc(C(=O)O)c1","inchiKey":"HQLQTGGLHBYZSA-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257468","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08551"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259898","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"CZWCKYRVOZZJNM-USOAJAOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRASTERONE SULFURIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prasterone sulfuric acid"],"crossReferences":{"drugbank":["DB05804"],"chEBI":["16814"]},"childChemblIds":["CHEMBL1573900","CHEMBL89908","CHEMBL1551864","CHEMBL3188432"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262616","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cccc(-c2ccc(-c3ccccc3)cc2)c1)P(=O)(O)O","inchiKey":"MPBUFKZCEBTBSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(1-Hydroxy-1-Phosphono-2-[1,1';4',1'']Terphenyl-3-Yl-Ethyl)-Phosphonic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(1-Hydroxy-1-Phosphono-2-[1,1';4',1'']Terphenyl-3-Yl-Ethyl)-Phosphonic Acid"],"crossReferences":{"drugbank":["DB07409"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272980","canonicalSmiles":"Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1","inchiKey":"HRNLUBSXIHFDHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOCETINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGCD-0103","MGCD0103","Mocetinostat"],"crossReferences":{"PubChem":["137276026"],"Wikipedia":["Mocetinostat"],"drugbank":["DB11830"]},"childChemblIds":["CHEMBL481122"],"count":15,"linkedTargets":{"rows":["ENSG00000163517","ENSG00000147099","ENSG00000116478","ENSG00000171720","ENSG00000196591"],"count":5},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000756","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0000565","EFO_0000564","EFO_0000095","MONDO_0008903","EFO_0000199","EFO_0000574","EFO_0002918","EFO_0008528","MONDO_0018906","EFO_0000183"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL279115","canonicalSmiles":"CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O","inchiKey":"PHEDXBVPIONUQT-RGYGYFBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHORBOL MYRISTATE ACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-262244","Phorbol 12-myristate 13-acetate diester","Phorbol myristate acetate"],"crossReferences":{"PubChem":["26755285"],"Wikipedia":["12-O-Tetradecanoylphorbol-13-acetate"],"chEBI":["37537"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL298445","canonicalSmiles":"Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1","inchiKey":"DYTKVFHLKPDNRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL298445","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02833"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039500","canonicalSmiles":"CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"JYFKDBFPRXMUAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLVATINIB TARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3039525","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ER-396901-08","Golvatinib tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039521","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)c5ccc(NCc6cnc7[nH]c(N)nc(=O)c7n6)cc5)C(=O)O)C(=O)O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"KUZYSQSABONDME-QRLOMCMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINTAFOLIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EC-145","EC145","Vintafolide"],"crossReferences":{"drugbank":["DB05168"]},"count":6,"linkedTargets":{"rows":["ENSG00000110195"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000571","MONDO_0008170","EFO_0003060","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL307429","canonicalSmiles":"OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LXBIFEVIBLOUGU-JGWLITMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUVOGLUSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deoxynojirimycin","Duvoglustat"],"crossReferences":{"PubChem":["26752140"],"drugbank":["DB03206"],"chEBI":["44369"]},"childChemblIds":["CHEMBL460785"],"linkedTargets":{"rows":["ENSG00000171298"],"count":1},"linkedDiseases":{"rows":["Orphanet_365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3137320","canonicalSmiles":"Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1","inchiKey":"HWGQMRYQVZSGDQ-HZPDHXFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAZOPARIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BMN 673","BMN-673","LT-673","Talazoparib"],"crossReferences":{"DailyMed":["talazoparib%20tosylate"],"drugbank":["DB11760"]},"childChemblIds":["CHEMBL3137318"],"count":20,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484"],"count":2},"linkedDiseases":{"rows":["EFO_1000253","EFO_0000616","EFO_0002618","EFO_0003869","Orphanet_145","EFO_1001958","MONDO_0015686","MONDO_0008170","EFO_0000681","MONDO_0007254","EFO_0000222","EFO_0000708","EFO_0000305","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0000565","EFO_0000304","EFO_0003968","EFO_0005537","MONDO_0011962","EFO_0000702","EFO_0000673","EFO_0000196","MONDO_0024880","EFO_1000494"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for cancer and neoplasm and has 18 investigational indications."}
{"id":"CHEMBL3137358","canonicalSmiles":"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)[N-]S(=O)(=O)C6CC6)C[C@H]5/C=C\\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C.[Na+]","inchiKey":"LLXQGDWGCCKOQP-MVZLLIIPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMEPREVIR SODIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL501849","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olysio"],"synonyms":["Simeprevir sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013."}
{"id":"CHEMBL3137693","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-175","Gold","INS NO.175","INS-175"],"crossReferences":{"chEBI":["30050"]},"childChemblIds":["CHEMBL3833324"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3181832","canonicalSmiles":"COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"NRZPASQBOYNGHR-HWROMZCQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHICILLIN SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL575","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celbenin","Staphcillin"],"synonyms":["BRL-1241","Methicillin sodium","Meticillin sodium","SQ 16,123","SQ-16123","X-1497"],"crossReferences":{"PubChem":["144204873","170465152"],"chEBI":["34836"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL334255","canonicalSmiles":"CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]","inchiKey":"DVBJBNKEBPCGSY-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CETYLPYRIDINIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL305906","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Hexadecyl-Pyridinium Bromide","1-Hexadecylpyridinium Bromide","Cetylpyridinium Bromide"],"crossReferences":{"PubChem":["144204612","144208747","144213748","170465500","17389115","89856150"],"chEBI":["77052"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL334830","canonicalSmiles":"O=C1C[C@@]2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1cccn12","inchiKey":"QCVNMNYRNIMDKV-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANIRESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-3201","Ranirestat"],"crossReferences":{"drugbank":["DB05327"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL335062","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"CBMYJHIOYJEBSB-KHOSGYARSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTANDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Androstandiol"],"crossReferences":{"PubChem":["8139870"],"drugbank":["DB01530"],"chEBI":["36713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL338790","canonicalSmiles":"Nc1ccc2c3c(cccc13)C(=O)NC2=O","inchiKey":"SSMIFVHARFVINF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL338790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110714","124879101","26753511","26753512","50105795","85230895","90340784"],"drugbank":["DB07096"],"chEBI":["40071"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL350239","canonicalSmiles":"CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21","inchiKey":"FJLGEFLZQAZZCD-JUFISIKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL350239","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26758026"],"drugbank":["DB01095"],"chEBI":["5136"]},"childChemblIds":["CHEMBL241778"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL353861","canonicalSmiles":"NS(=O)(=O)c1cc2c(s1)S(=O)(=O)N(c1cccc(O)c1)C(CN1CCOCC1)=C2","inchiKey":"PZLYYZPXSSNGJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AL-6619","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-6619"],"crossReferences":{"drugbank":["DB03262"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545005","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-8394","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX8394","Plx 8394","Plx-8394"],"count":8,"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000956","MONDO_0002108","EFO_0000756","HP_0100727","EFO_0003060","EFO_0005221","EFO_1001951"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545025","drugType":"Small molecule","blackBoxWarning":false,"name":"INSM-18","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Insm-18"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545047","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-852927","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-852927","XL-041"],"count":1,"linkedTargets":{"rows":["ENSG00000131408","ENSG00000025434"],"count":2},"linkedDiseases":{"rows":["HP_0003124"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545096","canonicalSmiles":"COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1.O=C(O)/C=C\\C(=O)O","inchiKey":"YUXMAKUNSXIEKN-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BGT-226","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3218578","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGT226","Bgt-226","NVP-BGT-226","NVP-BGT226"],"crossReferences":{"chEBI":["71953"]},"count":3,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["Orphanet_201","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545102","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-773812","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW773812","SB-737050-A","SB-773812","Sb-773812"],"count":1,"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000692"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545103","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD3199","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd3199"],"count":2,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545128","drugType":"Cell","blackBoxWarning":false,"name":"ROCAPULDENCEL-T","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Arcelis"],"synonyms":["AGS-003","AGS-003 MDCS","AGS-003 MDCs for drug substance AGS-003 for drug product","Ags-003","Rocapuldencel-t"],"count":2,"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545145","drugType":"Small molecule","blackBoxWarning":false,"name":"WX-554","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Wx-554"],"count":1,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545185","canonicalSmiles":"O=C(/C=C\\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1","inchiKey":"DEVSOMFAQLZNKR-RJRFIUFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELINEXOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xpovio"],"synonyms":["KPT-330","Selinexor"],"crossReferences":{"DailyMed":["selinexor"],"drugbank":["DB11942"]},"count":27,"approvedIndications":["EFO_0000616","EFO_0001378","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000082898"],"count":1},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0000756","EFO_1001465","EFO_1000657","MONDO_0007254","EFO_0000708","EFO_0003085","EFO_1001459","EFO_0000339","EFO_0000096","MONDO_0020743","EFO_0000707","MONDO_0002083","EFO_0000198","EFO_0000616","EFO_0000220","EFO_0001642","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_1001968","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0000211","EFO_1000581","MONDO_0100096","MONDO_0011962","EFO_0000702","EFO_0004142","EFO_0001378","EFO_0000691","EFO_0000519"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 24 investigational indications."}
{"id":"CHEMBL3545238","drugType":"Small molecule","blackBoxWarning":false,"name":"CS-8080","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cs-8080"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545312","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3cc(-c4ccc5[nH]c([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc3c2)c[nH]1)C(C)C.Cl.Cl","inchiKey":"JYLMWUZJMRNMDA-SPRBZRACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVIDASVIR HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3121849","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 238630 CL2","BI-238630-CL2","BL-238630 DIHYDROCHLORIDE","PPI-668","Ravidasvir hydrochloride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545340","canonicalSmiles":"CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4c(c3)NC(=O)C(F)(F)O4)n2)c1.O=C(O)c1ccc2ccccc2c1O","inchiKey":"ILIHENOWEIBEQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-343","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2170582","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-343"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545415","drugType":"Protein","blackBoxWarning":false,"name":"SMC021","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Smc021"],"count":4,"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0002506","EFO_0003854","EFO_0003882","EFO_0003922"],"count":4},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL354773","canonicalSmiles":"O=C(O)c1ncccc1CP(=O)(O)O","inchiKey":"ROSWJUKEABEPFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL354773","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04406"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3559901","canonicalSmiles":"CCC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](OC(=O)CC)[C@@H]2OC(=O)CC","inchiKey":"ONMZMZJEZHMWQL-REUUDLSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3559901","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170465876"],"drugbank":["DB14641"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL356359","canonicalSmiles":"CCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1","inchiKey":"KVCSJPATKXABRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIBOSEROD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piboserod","SB-207266"],"crossReferences":{"PubChem":["137275879"],"Wikipedia":["Piboserod"],"drugbank":["DB04873"]},"childChemblIds":["CHEMBL2106927"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL358150","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1","inchiKey":"XXRVYAFBUDSLJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etofibrate"],"crossReferences":{"Wikipedia":["Etofibrate"],"drugbank":["DB08983"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL363648","canonicalSmiles":"CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1","inchiKey":"HEKAIDKUDLCBRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-715","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK 715","TAK-715","Tak-715"],"crossReferences":{"PubChem":["103905024","174006984"]},"count":1,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL364713","canonicalSmiles":"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C","inchiKey":"AKNNEGZIBPJZJG-MSOLQXFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOSCAPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tusscapine"],"synonyms":["NSC-5366","Narcotine","Noscapine"],"crossReferences":{"PubChem":["11113349","144203964","170465539","49645498","50104123","71491","855860","90341457"],"Wikipedia":["Noscapine"],"drugbank":["DB06174"],"chEBI":["73237"]},"childChemblIds":["CHEMBL2106732"],"count":3,"approvedIndications":["HP_0012735"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cough and has 2 investigational indications."}
{"id":"CHEMBL3707218","canonicalSmiles":"O=C1N(Cc2ccc(C(F)(F)F)o2)c2ccccc2[C@]12COc1cc3c(cc12)OCO3","inchiKey":"NEBUOXBYNAHKFV-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUNAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Funapide","TV-45070","Tv-45070","XEN-401-S","XEN-402","XEN402","XPF-002"],"crossReferences":{"drugbank":["DB11769"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707249","drugType":"Small molecule","blackBoxWarning":false,"name":"ASM-024","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asm-024"],"count":2,"linkedTargets":{"rows":["ENSG00000175344","ENSG00000133019","ENSG00000181072","ENSG00000080644","ENSG00000168539","ENSG00000117971"],"count":6},"linkedDiseases":{"rows":["EFO_0000270","EFO_0000341","MONDO_0004784"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707258","canonicalSmiles":"OC(CI)CI","inchiKey":"DNKPFCQEGBJJTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIIODOHYDROXYPROPANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diiodohydroxypropane"],"crossReferences":{"drugbank":["DB13383"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL385587","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)C1=O","inchiKey":"ICLOZQFWTRAYPX-LIRRHRJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385587","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07847"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL385711","canonicalSmiles":"C[C@@H]1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F","inchiKey":"SWKGZJAAGSVROJ-MWLCHTKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385711","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3918638","canonicalSmiles":"[2H]C([2H])([2H])Oc1cc(OC([2H])([2H])[2H])cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C([2H])([2H])C([2H])([2H])NC(C)C)c1","inchiKey":"OLAHOMJCDNXHFI-RCEBUFFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3918638","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545376","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989478","canonicalSmiles":"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"RVBRTNPNFYFDMZ-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIETHYLPERAZINE MALEATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1378","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Torecan"],"synonyms":["GS-95","Thiethylperazine maleate","Thietylperazine maleate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL3989522","canonicalSmiles":"O.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+]","inchiKey":"JHECKPXUCKQCSH-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":true,"name":"EDETATE CALCIUM DISODIUM","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200375","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcium Disodium Edetate","Calcium Disodium Edta","Calcium Edetate Sodium","Calcium Edta","Calcium disodium versenate","Edta Calcium Disodium","Edthamil","Ledclair","Sodium Calcium Edetate","Sodium Calciumedetate","Versene Ca"],"synonyms":["Calcium disodium edetate","Calcium tetracemine disodium","Calciumedetate sodium","Edathamil","Edetate calcium disodium","Edta calcium","Sodium calcium edetate","Sodium calciumedetate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989571","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.Cl.Cl.O.O.O.O.O","inchiKey":"DCHJOVNPPSBWHK-UXXUFHFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPECTINOMYCIN HYDROCHLORIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1167","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actinospectacin","Espectinomicina","Spectam","Stanilo","Trobicin"],"synonyms":["Spectinomycin hydrochloride","U-18,409AE"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1971."}
{"id":"CHEMBL3989766","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"PWTROOMOPLCZHB-BHYQHFGMSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"ORITAVANCIN DIPHOSPHATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1688530","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orbactiv"],"synonyms":["LY-333328 DIPHOSPHATE","LY333328 DIPHOSPHATE","Oritavancin diphosphate"],"crossReferences":{"DailyMed":["oritavancin%20diphosphate"]},"count":4,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 4 investigational indications."}
{"id":"CHEMBL3989990","drugType":"Antibody","blackBoxWarning":false,"name":"ISTIRATUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Istiratumab","MM-005","MM-141"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL401974","canonicalSmiles":"CC(C)CCn1c(=O)c(C2=Nc3ccc(NS(C)(=O)=O)cc3S(=O)(=O)N2)c(O)c2cccn21","inchiKey":"FTVCONULIKITPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401974","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4103116","canonicalSmiles":"CO/N=[14C](/N)c1ccc(-c2ccc(-c3ccc(/[14C](N)=N\\OC)cc3)o2)cc1","inchiKey":"UKOQVLAXCBRRGH-OTVBAXJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4103116","maximumClinicalTrialPhase":0,"parentId":"CHEMBL319669","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL411084","canonicalSmiles":"CN(C)C[C@H](O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21","inchiKey":"XUBJEDZHBUPBKL-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WISKOSTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01731"],"chEBI":["78011"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4129312","canonicalSmiles":"[2H]c1cc(Cl)c(-c2ccccn2)c([2H])c1NC(=O)c1ccc(S(C)(=O)=O)cc1Cl","inchiKey":"BPQMGSKTAYIVFO-ZWXZTXIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4129312","maximumClinicalTrialPhase":0,"parentId":"CHEMBL473417","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4228250","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C","inchiKey":"LGANPTNILMNMES-TVNHODDRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SOR-C13","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sor-c13"],"crossReferences":{"drugbank":["DB15366"]},"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL423192","canonicalSmiles":"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1","inchiKey":"YKJYKKNCCRKFSL-RDBSUJKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-4549","TCMDC-125504"],"crossReferences":{"PubChem":["117834","26752154","47193747"],"Wikipedia":["Anisomycin"],"drugbank":["DB07374"],"chEBI":["338412"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4280766","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O[C@@H]2C(C(=O)O)O[C@@H](O[C@@H]3[C@@H](CO)O[C@H](O[C@@H](CO)C(O[C@H](O)CO)C(=O)O)[C@H](NC(C)=O)[C@H]3O)[C@H](OS(=O)(=O)O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"YUQCJZVVMQZBFE-JPUFUMQZSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"RONEPARSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Roneparstat"],"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4283683","canonicalSmiles":"Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1","inchiKey":"PRXXYMVLYKJITB-IZZDOVSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMATINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4sc-202","Domatinostat"],"crossReferences":{"drugbank":["DB13101"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297325","canonicalSmiles":"C=CCc1c(OC(=O)N2CCC(N3CCCCC3)CC2)ccc2nc3c(cc12)Cn1c-3cc2c(c1=O)COC(=O)[C@]2(O)CC.Cl","inchiKey":"UWNITDCAZZJJFF-GXUZKUJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMMITECAN","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4301491","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simmitecan"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297414","canonicalSmiles":"COC(=O)C[C@@]1(CN)C[C@@H]2CC[C@@H]2C1","inchiKey":"ASBDKEXHKWHAPE-JZYVYDRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-217014","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pd-217,014","Pd-217014"],"crossReferences":{"drugbank":["DB12493"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297494","canonicalSmiles":"O=C(CCc1ccc(CN[C@H](C(=O)OC2CCCC2)C2CCCCC2)cn1)NO","inchiKey":"AFDPFLDWOXXHQM-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-3117391","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYCLOHEXANEACETIC ACID, .ALPHA.-(((6-(3-(HYDROXYAMINO)-3-OXOPROPYL)-3-PYRIDINYL)METHYL)AMINO)-, CYCLOPENTYL ESTER, (.ALPHA.S)-","GSK-3117391","GSK3117391","Gsk-3117391","Gsk3117391"],"crossReferences":{"drugbank":["DB15440"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297519","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](/C(N)=N/O[C@@H](C)c3nnc(-c4ccccn4)s3)C(=O)O[C@@]21C","inchiKey":"RLFCSBSRGRJFRO-QAOQTAGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFITHROMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nafithromycin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297774","drugType":"Unknown","blackBoxWarning":false,"name":"JNJ-61186372","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amivantamab","CNTO-4424","JNJ-611","JNJ-61186372","Jnj 61186372","Jnj-61186372"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297785","drugType":"Antibody","blackBoxWarning":false,"name":"VIBOSTOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-7684","MK7684","Mk-7684","TIGIT INHIBITOR MK-7684","TIGIT-TARGETING AGENT MK-7684","Vibostolimab"],"count":3,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297880","drugType":"Unknown","blackBoxWarning":false,"name":"ALX-148","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX148","Alx 148","Alx-148","Alx148"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298038","drugType":"Unknown","blackBoxWarning":false,"name":"MGD-007","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mgd-007","Mgd007"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298040","drugType":"Antibody","blackBoxWarning":false,"name":"GEDIVUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gedivumab","MHAA4549A","Mhaa4549a","RG7745","RO6876802"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4302505","canonicalSmiles":"CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1","inchiKey":"DYTOQURYRYYNOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSI-189","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nsi-189"],"childChemblIds":["CHEMBL4297309"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL436784","canonicalSmiles":"O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1","inchiKey":"ULBPQWIGZUGPHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LGD-2226","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGD-2226"],"crossReferences":{"drugbank":["DB08089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4442431","canonicalSmiles":"C[C@@H](C(=O)[N-]S(C)(=O)=O)c1ccc(OS(=O)(=O)C(F)(F)F)cc1.[Na+]","inchiKey":"QICAUCDBOAKDNS-OGFXRTJISA-M","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4442431","maximumClinicalTrialPhase":0,"parentId":"CHEMBL189475","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL447861","canonicalSmiles":"O=C(OCc1ccccc1)c1ccc(O)cc1","inchiKey":"MOZDKDIOPSPTBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Hydroxy Benzoic Acid Benzyl Ester","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Hydroxy Benzoic Acid Benzyl Ester"],"crossReferences":{"PubChem":["144205641","144212647","170465711","26757572"],"drugbank":["DB14176"],"chEBI":["34571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45068","canonicalSmiles":"O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O","inchiKey":"VGEREEWJJVICBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHLORETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2',4,4',6'-Tetrahydroxy-Dihydrochalcone","2',4,4',6'-Tetrahydroxydihydrochalcone","Phloretin"],"crossReferences":{"PubChem":["11111666","11111667","124881191","124881192","124881194","144210052","174006856","26725279","26747651","26753632","46500461","50106910","50106911","85231195","90341086"],"drugbank":["DB07810"],"chEBI":["17276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4524066","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(=O)O","inchiKey":"VXEVKSKAINMPFG-QWUNSSNDSA-N","drugType":"Protein","blackBoxWarning":true,"name":"LIRAGLUTIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Saxenda","Victoza"],"synonyms":["Liraglutide","Liraglutide recombinant","NN-2211","NN-9924","NN2211","NN9924","NNC 90-1170","NNC-90-1170"],"crossReferences":{"DailyMed":["liraglutide","liraglutide%20recombinant"]},"count":22,"approvedIndications":["Orphanet_552","EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0000275","EFO_0003095","EFO_0000401","EFO_0000249","EFO_1001249","HP_0001824","EFO_0005924","EFO_0004593","EFO_0000289","EFO_0003144","MONDO_0015183","EFO_0004616","EFO_0000400","EFO_0003877","EFO_0002546","EFO_0004319","EFO_0005203","EFO_0001074","HP_0002024","EFO_0002508","EFO_0001073","EFO_0000195","EFO_0002614","EFO_1001121","EFO_0001359","HP_0003074","Orphanet_552","EFO_0000341","EFO_0005611","EFO_0001360"],"count":31},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL452867","canonicalSmiles":"CC(C)=CCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"USVMJSALORZVDV-SDBHATRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOPRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPA","N6-Isopentenyladenosine","Riboprine"],"crossReferences":{"PubChem":["170466472"],"drugbank":["DB11933"],"chEBI":["62881"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453087","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O","inchiKey":"CFCMMYICHMLDCC-RMIBZTJPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTOMYCIN SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL372795","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Agri-Strep","Streptomycin Sulfate","Streptorex","Vetstrep"],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457047","canonicalSmiles":"NS(=O)(=O)c1cccc2c(O)cccc12","inchiKey":"NFVBVKHGDDDCEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL457047","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457299","canonicalSmiles":"OCCO","inchiKey":"LYCAIKOWRPUZTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACROGOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1,2-Ethanediol","Ethylene Glycol","Macrogol"],"crossReferences":{"DrugCentral":["4253"],"PubChem":["144209236","144210954","17389886","85272555"],"Wikipedia":["Ethylene_glycol"],"chEBI":["30742"]},"count":2,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL4594430","canonicalSmiles":"CC(C)c1nc2c([nH]1)C(=O)C(=O)c1ccccc1-2","inchiKey":"AJFWITSBVLLDCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KL-1333","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KL-1333","KL1333","Kl-1333","Kl1333"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46148","canonicalSmiles":"N=C(N)c1ccc2[nH]c(Cc3nc4ccccc4[nH]3)nc2c1","inchiKey":"KKJYVDXDZURHMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46148","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL466659","canonicalSmiles":"O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]","inchiKey":"TZRXHJWUDPFEEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAERYTHRITOL TETRANITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardiacap","Mycardol","Pentritol tempules","Peritrate","Peritrate sa"],"synonyms":["Pentaerithritol tetranitrate","Pentaerithrityl tetranitrate","Pentaerythritol tetranitrate","Pentalong","Pentanitrol"],"crossReferences":{"PubChem":["144205177","144212064","29215318"],"Wikipedia":["Pentaerythritol_tetranitrate"],"drugbank":["DB06154"],"chEBI":["25879"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL468","canonicalSmiles":"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1","inchiKey":"UEJJHQNACJXSKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THALIDOMIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Talidex","Thalomid"],"synonyms":["K-17","NSC-527179","NSC-66847","Thalidomide","Thalidomide "],"crossReferences":{"DailyMed":["thalidomide"],"PubChem":["111716","11532929","124881523","144210897","170465323","174007312","26747126","26751823","50104514","90341724"],"Wikipedia":["Thalidomide"],"drugbank":["DB01041"],"chEBI":["74947"]},"count":81,"approvedIndications":["EFO_0001378","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000139842","ENSG00000113851","ENSG00000167986","ENSG00000100387"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000403","EFO_0005543","EFO_0000365","HP_0012735","EFO_0000756","EFO_0000249","EFO_0000681","EFO_0005952","EFO_0000540","HP_0003073","Orphanet_85443","EFO_1001951","EFO_0000565","EFO_0007312","EFO_0007160","EFO_1000318","EFO_0000096","EFO_0002690","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000676","EFO_0000253","EFO_1000045","EFO_0000198","EFO_0009441","MONDO_0008170","EFO_0002939","EFO_1001968","EFO_0000384","MONDO_0008315","MONDO_0002691","Orphanet_398934","EFO_1001231","MONDO_0100096","MONDO_0019472","EFO_0000574","EFO_1000613","EFO_0001378","EFO_0000342","MONDO_0015564","Orphanet_314701","MONDO_0044903","EFO_1001984","EFO_0001065","EFO_1001901","EFO_0000768","MONDO_0007254","MONDO_0003196","EFO_0000373","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0002430","EFO_0006888","MONDO_0001056","MONDO_0002158","EFO_0000474","EFO_1001480","EFO_1001974","EFO_1001996","EFO_0000673","EFO_0000326","EFO_0000183","EFO_0003047","EFO_0000717","EFO_1000158","Orphanet_797","EFO_0000616","EFO_0006859","EFO_0000765","EFO_0008572","EFO_0001645","EFO_0000403","EFO_0003898","MONDO_0007576","EFO_1001875","MONDO_0019558","EFO_0003843","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0003834","EFO_0005570","EFO_0003865","EFO_0004268","EFO_0000095","EFO_1001767","EFO_0000764","EFO_0004142","EFO_0000191","MONDO_0002367","MONDO_0018906","EFO_0000691","EFO_0000519"],"count":96},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for multiple myeloma and immune system disease and has 79 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL469912","canonicalSmiles":"COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1","inchiKey":"RXWNCPJZOCPEPQ-NVWDDTSBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PUROMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3123L","CL 13,900","GNF-Pf-2016","P-638","Puromycin","TCMDC-123493"],"crossReferences":{"drugbank":["DB08437"],"chEBI":["17939"]},"childChemblIds":["CHEMBL531268","CHEMBL2104870"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL471737","canonicalSmiles":"COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2","inchiKey":"ACRHBAYQBXXRTO-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IVABRADINE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corlanor","Procoralan"],"synonyms":["Ivabradine","S-16257"],"crossReferences":{"DailyMed":["ivabradine","ivabradine%20hydrochloride"],"PubChem":["50125937"],"Wikipedia":["Ivabradine"],"drugbank":["DB09083"],"chEBI":["85966"]},"childChemblIds":["CHEMBL2145077"],"count":17,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000138622"],"count":1},"linkedDiseases":{"rows":["EFO_0007372","EFO_0008586","HP_0001649","EFO_0006834","EFO_0000275","EFO_0000401","EFO_0001645","EFO_0005252","EFO_0000373","EFO_0000319","EFO_0000311","EFO_0003913","GO_0007568","EFO_0003144","EFO_0000574","EFO_1001373","EFO_0000341","EFO_1001207","HP_0031273","EFO_0005672","EFO_0005251","EFO_1000899"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for cardiovascular disease and has 16 investigational indications."}
{"id":"CHEMBL478718","canonicalSmiles":"NCCCC(=O)Nc1ccc(OCc2ccccc2)cc1","inchiKey":"QTWBKNVNGVYTNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL480411","canonicalSmiles":"CC(C)(C)NS(=O)(=O)c1ccc(-c2ccc3[nH]nc(N)c3c2)cc1","inchiKey":"KFJCXIOVAGJCKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL480411","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07162"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489157","canonicalSmiles":"NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12","inchiKey":"OGKYMFFYOWUTKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03693"],"chEBI":["47322"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL500082","canonicalSmiles":"O=c1[nH]c(Cl)c(CCCCOP(=O)(O)O)c(=O)[nH]1","inchiKey":"DAUATIBSDSXXHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500082","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08016"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL521851","canonicalSmiles":"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1","inchiKey":"LHNIIDJUOCFXAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICTILISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDC-0941","GDC 0941","GDC-0941","Pictilisib","Rg-7321"],"crossReferences":{"PubChem":["103905592"],"drugbank":["DB11663"],"chEBI":["65326"]},"childChemblIds":["CHEMBL4097197","CHEMBL1922096"],"count":5,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0005952","EFO_0003060","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL524","canonicalSmiles":"COc1ccc(OC)c(C(O)C(C)N)c1","inchiKey":"WJAJPNHVVFWKKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methoxamine","NRL-001","NRL001","Nrl001","Vasoxyl"],"crossReferences":{"PubChem":["90341132"],"Wikipedia":["Methoxamine"],"drugbank":["DB00723"],"chEBI":["6839"]},"childChemblIds":["CHEMBL1201103"],"count":3,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["HP_0000020","EFO_0000319","EFO_0009523"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL542541","canonicalSmiles":"Cl.NNc1nncc2ccccc12","inchiKey":"ZUXNZUWOTSUBMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDRALAZINE HYDROCHLORIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL276832","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apresoline","Dralzine","Hydralazine hydrochloride"],"synonyms":["Hydralazine hydrochloride","MC-1101","NSC-89394"],"crossReferences":{"DailyMed":["hydralazine%20hydrochloride"],"PubChem":["144203714","144212813","170464806","26747529","26747530","50106396","50106397"],"chEBI":["31672"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 3 investigational indications."}
{"id":"CHEMBL551043","canonicalSmiles":"Cc1csc(NC(=O)c2nc(Sc3nncn3C)ccc2Sc2ccc(F)cc2)n1","inchiKey":"SJTQKYKXCYVFHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL551043","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07359"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL57531","canonicalSmiles":"Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1","inchiKey":"HGIPWJYTPOHUGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL57531","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08144"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL578211","canonicalSmiles":"CN1C(=O)CC[C@H]1c1cccnc1","inchiKey":"UIKROCXWUNQSPJ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COTININE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cotinine","Nicotine related compound c"],"crossReferences":{"PubChem":["144204770","170466160","26753539","50106041","50106042","50106043","50106044","90341278"],"Wikipedia":["Cotinine"],"chEBI":["68641"]},"childChemblIds":["CHEMBL3989573"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL579205","canonicalSmiles":"CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F","inchiKey":"VVECGOCJFKTUAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTEMETAMOL","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Flutemetamol","[3H]-Flutemetamol"],"crossReferences":{"DailyMed":["flutemetamol%20f-18"],"drugbank":["DB15058"]},"childChemblIds":["CHEMBL2042122"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and has 1 investigational indication."}
{"id":"CHEMBL589752","canonicalSmiles":"N=C(N)NCCCC[C@H](N)C(=O)O","inchiKey":"QUOGESRFPZDMMT-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-Homoarginine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Homoarginine"],"crossReferences":{"drugbank":["DB03974"],"chEBI":["27747"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL604608","canonicalSmiles":"OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O","inchiKey":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRUCTOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dietade dietary foods"],"synonyms":["Fructose","Levulose","Topiramate impurity, fructose-"],"crossReferences":{"PubChem":["144207106","144207960"],"Wikipedia":["Fructose"],"chEBI":["28645"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL605993","canonicalSmiles":"COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"ZDUPYZMAPCZGJO-NSCGSSGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL605993","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1363","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL63895","canonicalSmiles":"O=C([C@@H]1CCCN1)N1CCC[C@H]1B(O)O","inchiKey":"XSBZZZGVAIXJLD-YUMQZZPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL63895","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07482"],"chEBI":["41285"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL72006","canonicalSmiles":"CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)CF","inchiKey":"JCRSHQCFRMCMOC-GSDHBNRESA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL72006","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04653"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL762","canonicalSmiles":"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1","inchiKey":"WYWIFABBXFUGLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYMETAZOLINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ocuclear","Oxymetazoline"],"crossReferences":{"DailyMed":["oxymetazoline%20hydrochloride"],"PubChem":["104171207","11111570","11111571","11113337","124880976","124880979","144203768","170464916","26751491","26751492","50100299","50104031","90341671"],"Wikipedia":["Oxymetazoline"],"drugbank":["DB00935"],"chEBI":["7862"]},"childChemblIds":["CHEMBL1200791"],"count":9,"approvedIndications":["EFO_0005751","HP_0001742"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0005854","MONDO_0001330","EFO_0009540","HP_0010783","EFO_1000906","EFO_0005252","HP_0001742","EFO_0007214","EFO_1000760","EFO_1000391","EFO_0002460","EFO_0007141","EFO_0009523","EFO_0005751","MONDO_0003276","EFO_0003956","EFO_0007415"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for eye allergy and nasal obstruction and has 7 investigational indications."}
{"id":"CHEMBL76222","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C","inchiKey":"GTXSRFUZSLTDFX-HRCADAONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBIMASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 275291-01","BMS-275291","BMS-275291-01","D-2163","D2163","Rebimastat"],"crossReferences":{"drugbank":["DB06573"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL8260","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12","inchiKey":"FXNFHKRTJBSTCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAICALEIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Baicalein","NSC-661431"],"crossReferences":{"PubChem":["11113153","11114203","124882850","124882851","124882853","26747176","50104952","85272355"],"Wikipedia":["Baicalein"],"chEBI":["2979"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL850","canonicalSmiles":"C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1","inchiKey":"DZZWHBIBMUVIIW-DTORHVGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPARFLOXACIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Dermatological toxicity"],"year":2001},"tradeNames":["Spara","Zagam"],"synonyms":["AT-4140","CI-978","Sparfloxacin"],"crossReferences":{"PubChem":["144205133","26719819","29218052"],"Wikipedia":["Sparfloxacin"],"drugbank":["DB01208"],"chEBI":["9212"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for bacterial disease and has 1 investigational indication. It was withdrawn in United States  in 2001 due to Cardiotoxicity and  Dermatological toxicity."}
{"id":"CHEMBL852","canonicalSmiles":"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O","inchiKey":"SGDBTWWWUNNDEQ-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MELPHALAN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aikeran","Alkeran"],"synonyms":["Alanine nitrogen mustard","CB 3025","CB-3025","L-sarcolysin","Melfalan","Melphalan","NCI-C04853","NSC-241286","NSC-8806","Phenylalanine mustard","SK 15673","SK-15673"],"crossReferences":{"DailyMed":["melphalan","melphalan%20hydrochloride"],"PubChem":["144204561","144209720","170464727","17389837","26752787","56463160"],"Wikipedia":["Melphalan"],"drugbank":["DB01042"],"chEBI":["28876"]},"childChemblIds":["CHEMBL1200863"],"count":96,"approvedIndications":["EFO_0000616","EFO_0000313","EFO_0001378","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 4 approved and 92 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL888","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1","inchiKey":"SDUQYLNIPVEERB-QPPQHZFASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMCITABINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"crossReferences":{"DailyMed":["gemcitabine%20hydrochloride"],"PubChem":["124893555","50113286"],"Wikipedia":["Gemcitabine"],"drugbank":["DB00441"],"chEBI":["175901"]},"childChemblIds":["CHEMBL1637"],"count":95,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000146143","ENSG00000062822","ENSG00000167325","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_0003891","EFO_0004708","EFO_0000637","EFO_0000365","EFO_0003859","EFO_0000756","EFO_0000681","EFO_1000231","EFO_0005952","EFO_1001951","EFO_1001952","MONDO_0015760","MONDO_0003059","EFO_0000588","EFO_0000096","EFO_0000564","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_0000514","EFO_0004606","MONDO_0021054","EFO_0009534","EFO_0002618","MONDO_0019465","EFO_1001973","EFO_1001968","MONDO_0008627","MONDO_0008315","EFO_0005221","EFO_1000026","Orphanet_398934","MONDO_0002691","MONDO_0044889","EFO_0003032","MONDO_0019472","EFO_0000574","EFO_0001378","EFO_0001376","EFO_1000412","EFO_0000292","MONDO_0021117","EFO_0002913","MONDO_0007254","EFO_0000255","EFO_0004252","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_1001974","EFO_0000183","EFO_0000707","EFO_0000616","EFO_0005088","EFO_0006859","EFO_1000314","EFO_0000403","Orphanet_44890","MONDO_0007576","EFO_1001961","EFO_0000304","Orphanet_238510","EFO_0002517","MONDO_0011962","EFO_0000702","MONDO_0002367","MONDO_0018906","MONDO_0024880","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_1001958","MONDO_0003890","EFO_0000571","EFO_1000657","EFO_0002426","EFO_0000228","EFO_0000565","EFO_1001331","EFO_0000182","MONDO_0005411","MONDO_0003000","EFO_0001416","Orphanet_145","EFO_0003893","EFO_1001956","EFO_0000466","EFO_0000220","EFO_1000292","MONDO_0002108","MONDO_0008170","MONDO_0021321","EFO_0005842","EFO_0002939","EFO_1001959","EFO_0009708","EFO_0000294","EFO_0001061","EFO_1001100","EFO_0005537","EFO_0006544","EFO_1001051","EFO_1000613","EFO_1000624","EFO_1000172","MONDO_0009348","EFO_0006718","MONDO_0019471","MONDO_0004192","MONDO_0015686","EFO_1001469","EFO_0000708","MONDO_0002087","MONDO_0021063","MONDO_0024879","EFO_0000305","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000218","EFO_1000043","EFO_0003860","EFO_0000770","MONDO_0001657","EFO_0005230","EFO_1001963","EFO_0002914","EFO_0000313","EFO_0003060","EFO_0000311","EFO_0006738","EFO_0000211","HP_0001907","EFO_0003863","EFO_0010282","EFO_0006861","EFO_0006475","EFO_0003050","EFO_0000691"],"count":140},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for neoplasm and cancer and has 93 investigational indications."}
{"id":"CHEMBL900","canonicalSmiles":"Cc1ccccc1C(OCCN(C)C)c1ccccc1","inchiKey":"QVYRGXJJSLMXQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORPHENADRINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Disipal","Invagesic","Mefenamine","Norflex","Norgesic","Orphenadrine","Orphengesic"],"crossReferences":{"DailyMed":["orphenadrine%20citrate"],"PubChem":["124880989","174006927","90341796"],"Wikipedia":["Orphenadrine"],"drugbank":["DB01173"],"chEBI":["7789"]},"childChemblIds":["CHEMBL1201023","CHEMBL1200395"],"count":1,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000103546","ENSG00000116032","ENSG00000136546","ENSG00000198785","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000161509","ENSG00000185313","ENSG00000183873","ENSG00000144285","ENSG00000105464","ENSG00000169432","ENSG00000196639","ENSG00000176884","ENSG00000136531","ENSG00000153253"],"count":19},"linkedDiseases":{"rows":["EFO_0002508","HP_0003419","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and has 1 investigational indication."}
{"id":"CHEMBL959","canonicalSmiles":"CC(N)C12CC3CC(CC(C3)C1)C2","inchiKey":"UBCHPRBFMUDMNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMANTADINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Rimantadin","Rimantadine"],"crossReferences":{"DailyMed":["rimantadine%20hydrochloride"],"PubChem":["174006857","29215455"],"Wikipedia":["Rimantadine"],"drugbank":["DB00478"]},"childChemblIds":["CHEMBL535396"],"count":1,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993 and is indicated for viral disease."}
